General information about company

Size: px

Start display at page:

Download "General information about company"

Bertha Jackson
5 years ago
Views:

1 General information about company Scrip code Name of company BERYL Drugs Ltd Result Type Main Format Class of security Equity Date of start of financial year Date of end of financial year Date of board meeting when results were approved Date on which prior intimation of the meeting for considering financial results was informed to the exchange Description of presentation currency INR Level of rounding used in financial results Thousands Reporting Quarter First quarter Nature of report standalone or consolidated Standalone Whether results are audited or unaudited Unaudited Segment Reporting Single segment Description of single segment Pharmaceutical Indusrty Start time of board meeting 12:00 End time of board meeting 13:30 file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 1/6

2 Particulars Financial Results Other than Bank 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy) A Date of start of reporting period B Date of end of reporting period C Whether results are audited or unaudited Unaudited Unaudited D Nature of report standalone or consolidated Standalone Standalone Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. 1 Revenue From Operations 2 Expenses Revenue from operations Other income Total Revenue (a) Cost of materials consumed (b) Purchases of stock-in-trade 0 0 (c) Changes in inventories of finished goods, work-inprogress and stock-in-trade (d) Employee benefit expense (e) Finance costs (f) Depreciation and amortisation expense (g) Other Expenses 1 Other Expenses Total other expenses Total expenses file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 2/6

3 Particulars Financial Results Other than Bank 3 months/ 6 months ended (ddmm-yyyy) Year to date figures for current period ended (dd-mm-yyyy) A Date of start of reporting period B Date of end of reporting period C Whether results are audited or unaudited Unaudited Unaudited D Nature of report standalone or consolidated Standalone Standalone Part I 3 Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. Profit before exceptional and extraordinary items and tax Exceptional items Profit before extraordinary items and tax Extraordinary items Profit before tax Current tax Deferred tax 0 0 Total tax expenses Net Profit Loss for the period from continuing operations Profit (loss) from discontinuing operations before tax Tax expense of discontinuing operations Net profit (loss) from discontinuing operation after tax Profit (loss) for period before minority interest Net profit (Loss) for the period file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 3/6

4 Financial Results Other than Bank Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (ddmm-yyyy) A Date of start of reporting period B Date of end of reporting period C Whether results are audited or unaudited Unaudited Unaudited D Nature of report standalone or consolidated Standalone Standalone Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. 17 Details of equity share capital Paid-up equity share capital Face value of equity share capital Details of debt securities 18 Reserves excluding revaluation reserve 20 Earnings per equity share Basic earnings (loss) per share from continuing and discontinued operations Diluted earnings (loss) per share from continuing and discontinued operations Disclosure of notes on financial results Textual Information(1) file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 4/6

5 Text Block Textual Information(1) 1. The Standalone results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meeting held on 07th July In accordance with the requirements of Clause 41 of the Listing Agreement with the Stock Exchange, the Statutory Auditors have performed a limited review of the Company s financial results for the quarter ended June 30, 2017 there are no qualifications. 3. The Income from Operations is from one segment namely Pharmaceutical Indusrty. 4. Previous period exp. have been regrouped / rearranged, wherever necessary. 5.taxes and depreciation are calculated on proportionate basis on annual estimated basis. 6. There were no Investors complaints pending at the beginning of the quarter and one complaint were received during the quarter ended June 30, file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 5/6

6 file:///c:/users/acer/desktop/bdl%20report%20fr%20june% html 6/6

General information about company

11/5/ BDL RESULTS SEPT REPORT.html General information about company Scrip code 524606 Name of company Result Type Class of security BERYL DRUGS LTD Main Format Equity Date of start of financial year 01